Unité d'immuno-hématologie pédiatrique, Hôpital Necker-Enfant Malades, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France;
Blood. 2013 Nov 28;122(23):3713-22. doi: 10.1182/blood-2013-06-508267. Epub 2013 Oct 2.
Monogenic interleukin-10 (IL-10) and IL-10 receptor (IL-10R) deficiencies cause very early onset severe inflammatory bowel disease. Here, we report that 5 patients with an IL-10R1 (n = 1) or IL-10R2 (n = 4) deficiency developed B-cell non-Hodgkin lymphoma between the ages of 5 and 6 years (which was recurrent in 1 patient). These lymphomas had some of the characteristics of diffuse large B-cell lymphomas and contained monoclonal, Epstein-Barr virus-negative germinal center B cells. The tumors displayed a remarkably homogeneous signature, with original activation of the nuclear factor κB pathway and a decrease in intratumor T-cell infiltration. Hence, IL-10R deficiency is associated with a high risk of developing B-cell lymphoma. Our results revealed an unexpected role of the IL-10R pathway in lymphomagenesis.
单基因白细胞介素-10(IL-10)和 IL-10 受体(IL-10R)缺乏会导致非常早发的严重炎症性肠病。在这里,我们报告了 5 名 IL-10R1(n = 1)或 IL-10R2(n = 4)缺乏的患者在 5 至 6 岁之间发生 B 细胞非霍奇金淋巴瘤(1 例患者为复发性)。这些淋巴瘤具有弥漫性大 B 细胞淋巴瘤的一些特征,并且含有单克隆、EB 病毒阴性的生发中心 B 细胞。肿瘤显示出非常一致的特征,核因子 κB 途径的原始激活和肿瘤内 T 细胞浸润减少。因此,IL-10R 缺乏与发生 B 细胞淋巴瘤的风险增加有关。我们的结果揭示了 IL-10R 途径在淋巴瘤发生中的意外作用。